Ecstasy: The Complete Guide: A Comprehensive Look at the Risks and Benefits of MDMA

• The world's leading experts on Ecstasy assess its therapeutic potential, social implications, and the dangers of unsupervised use.

• Includes chapters by Andrew Weil, Ralph Metzner, Douglas Rushkoff, Rabbi Zalman Schachter, Rick Doblin, and others.

• An ideal guide for parents and educators seeking a credible source of information.

Use of the drug Ecstasy, once confined to the teen rave scene and college campuses, is exploding across America, from high schools to upscale clubs. Described by users as the most intense euphoria they know and by detractors as a cause of brain damage and even death, Ecstasy has generated unprecedented levels of interest-and misinformation.

Written by the world's leading experts on MDMA, Ecstasy: The Complete Guide takes the first unbiased look at the risks and the benefits of this unique drug, including the science of how it works; its promise as a treatment for depression, post-traumatic stress disorder, chronic pain, and other illnesses; and how to minimize the risk of illicit use. Whether you are a raver, a concerned parent, or a professional wanting the most recent reports on MDMA research, Ecstasy: The Complete Guide provides the answers you need.

Julie Holland, M.D., is a psychiatrist who specializes in psycho-pharmacology and a clinical assistant professor of psychiatry at NYU School of Medicine. A recognized expert on street drugs, Dr. Holland has discussed Ecstasy in the Lancet, Harper’s, and the Washington Post and has provided expert perspective on the drug for numerous television programs, including the MTV series True Life. Other contributors to the book include Ralph Metzner, author of Maps Consciousness and Green Psychology; Andrew Weil, author of eight books including 8 Weeks to Optimum Health and Spontaneous Healing; Douglas Rushkoff, author of Cyberia and Ecstasy Club; Rabbi Zalman Schachter, author of From Age-ing To Sageing; and Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies. Royalties from the book will be donated to fund clinical MDMA research.